IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
1.030
+0.010 (0.98%)
At close: May 17, 2024, 4:00 PM
1.020
-0.010 (-0.97%)
After-hours: May 17, 2024, 7:30 PM EDT
IN8bio Stock Forecast
INAB's stock price has decreased by -62.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for IN8bio stock have an average target of 8.25, with a low estimate of 5.00 and a high estimate of 12.5. The average target predicts an increase of 700.97% from the current stock price of 1.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IN8bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 5 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +1,113.59% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,259.22% | Apr 10, 2024 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $7.5 | Strong Buy | Initiates | $7.5 | +628.16% | Mar 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,259.22% | Mar 15, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +385.44% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.38M
EPS This Year
-0.69
from -1.00
EPS Next Year
-0.58
from -0.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 29.0M | 150.2M | 244.1M | 328.2M |
| Avg | n/a | 9.4M | 48.6M | 85.5M | 194.1M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,500.1% | 402.0% | 283.7% |
| Avg | - | - | 418.1% | 75.9% | 126.9% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.65 | -0.44 | 0.80 | 1.51 | 1.81 |
| Avg | -0.69 | -0.58 | -0.23 | 0.02 | 1.24 |
| Low | -0.70 | -0.84 | -1.03 | -1.38 | 0.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 11,703.9% |
| Avg | - | - | - | - | 8,033.3% |
| Low | - | - | - | - | 4,511.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.